Aeterna Zentaris (NASDAQ: AEZS) announced the finalization of a co-marketing agreement with Armune BioScience, Inc. (“Armune”) that will allow the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE